Companies / LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc.

Nasdaq: LENZCIK 1815776SOLANA BEACH, CA

Financials · FY2025

Revenue$19.09M
Net income$-82.13M
Total debt—
Cash$24.21M
Diluted EPS$-2.85
Shares outstanding31.4M

Ownership

31.4M shares outstanding · as of Aug 5, 2026
0.25%Insiders
Ownership
Insiders0.25%77,289
10%+ / strategic16.68%5,240,441
Institutions95.98%30,156,891
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Schimmelpennink Evert B.CEOPresident, CEO and Secretary · Director
0.25%77,289
Chevallard Daniel R.FormerChief Financial Officer
0.04%12,886
George Jeffrey P.FormerDirector
0.02%5,592
Drapkin Kimberlee CDirector
——
Kolchinsky PeterFormerDirector · 10% owner
——
McCollum James WDirector
——
Odrich MarcChief Medical Officer
——
Olsson ShawnChief Commercial Officer
——
RA Capital Healthcare Fund LPFormerDirector · 10% owner
——
RA Capital Management, L.P.FormerDirector · 10% owner
——

Institutional holders 167

View all →
HolderValue% of shares
Fmr LLC$59.24M11.78%
Alpha Wave Global, LP$57.80M11.50%
Versant Venture Management, LLC$42.51M8.46%
RA Capital Management, L.P.$38.24M13.30%
UBS Group AG$25.15M5.00%
Vanguard Group Inc$21.14M4.20%
Franklin Resources, Inc.$17.54M3.49%
72 Investment Holdings, LLC$16.28M3.24%
BlackRock, Inc.$13.02M7.30%
Intrinsic Edge Capital Management LLC$9.12M1.81%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 27, 2026Schimmelpennink Evert B.
CEO
BuyCommon Stock$251.4K+28K
+57.09%
77,289
0.25% of shares
medium
Mar 27, 2026Chevallard Daniel R.
Executive
BuyCommon Stock$64.3K+8K
+139.25%
12,886
0.04% of shares
medium
Mar 27, 2026George Jeffrey P.
Director
BuyCommon Stock$49.9K+6K
5,592
0.02% of shares
low
Jun 15, 2026Drapkin Kimberlee C
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026RA Capital Management, L.P.
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026Thunen Shelley B
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jun 15, 2026McCollum James W
Director
GrantStock Option (right to buy)—+22K
22,100
0.07% of shares
low
Jan 2, 2026Odrich Marc
Executive
GrantRestricted Stock Unit—+14K
14,000
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ridgeback Capital Investments L.P.Passive13G/A—0—
BlackRock, Inc.Passive13G/A—1,537,723—
Fmr LLCPassive13G/A—3,702,718—
Millennium Management LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LENZ——52635N103—